Abstract
Remnant ablation by radioiodine is generally not recommended in patients presenting uni- or multifocal cancer
Original language | English |
---|---|
Pages (from-to) | 426-433 |
Number of pages | 8 |
Journal | Endocrine |
Volume | 44 |
Issue number | 2 |
DOIs | |
Publication status | Published - Oct 2013 |
Keywords
- Differentiated thyroid cancer
- Low-risk patients
- Microcarcinoma
- Radioiodine therapy
- Remnant ablation
ASJC Scopus subject areas
- Endocrinology
- Endocrinology, Diabetes and Metabolism